Organigram Holdings Inc. (NASDAQ:OGI - Get Free Report)'s share price rose 2.8% during trading on Monday . The company traded as high as $1.52 and last traded at $1.48. Approximately 451,790 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 947,989 shares. The stock had previously closed at $1.44.
Organigram Price Performance
The firm has a market cap of $157.93 million, a price-to-earnings ratio of -3.50 and a beta of 1.03. The firm has a fifty day simple moving average of $1.75 and a two-hundred day simple moving average of $1.73.
Institutional Trading of Organigram
A number of institutional investors have recently bought and sold shares of OGI. Toronto Dominion Bank increased its holdings in shares of Organigram by 803.7% in the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company's stock valued at $30,000 after purchasing an additional 14,876 shares during the period. Clear Harbor Asset Management LLC acquired a new stake in Organigram during the 2nd quarter valued at approximately $51,000. Canton Hathaway LLC boosted its holdings in shares of Organigram by 115.8% in the 2nd quarter. Canton Hathaway LLC now owns 41,000 shares of the company's stock valued at $63,000 after acquiring an additional 22,000 shares during the last quarter. Virtu Financial LLC purchased a new position in shares of Organigram during the first quarter worth $340,000. Finally, Baader Bank Aktiengesellschaft lifted its position in Organigram by 26.4% during the second quarter. Baader Bank Aktiengesellschaft now owns 252,852 shares of the company's stock valued at $388,000 after purchasing an additional 52,852 shares during the period. 34.63% of the stock is currently owned by institutional investors and hedge funds.
Organigram Company Profile
(
Get Free Report)
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Further Reading
Before you consider Organigram, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.
While Organigram currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
